Event Details
Dates: May 7 to 9, 2026
Location: Omni San Diego, 675 L St, San Diego, California
Event Website: https://www.ci4cc.org/spring-2026-society-conference
Event Overview
Cizzle Bio will attend the 25th Cancer Center Informatics Society (Ci4CC) Summit, a leading conference focused on advancing the role of data, informatics, and digital infrastructure in cancer research and care.
Chaired by City of Hope, the summit brings together leaders from academia, healthcare, government, life sciences, and technology to explore how interconnected data ecosystems can accelerate translational research and improve patient outcomes.
The program highlights the integration of clinical data, genomic insights, real-world evidence, and emerging technologies, with a focus on building scalable systems that enable data-driven decision making in precision oncology.
Featured Participation
Cizzle Bio CEO Bill Behnke will participate in a panel discussion chaired by City of Hope:
Commercialization of Cancer Therapeutics – “Bench to Bedside Drug Development Pipeline”
Date: May 9, 2026
Time: 3:30 PM PDT
This session will explore the pathway from discovery to clinical application, highlighting the challenges and opportunities in translating scientific innovation into real-world therapies.
Why Attend
Gain insight into data-driven innovation and cancer informatics shaping modern oncology.
Explore advancements in precision oncology, real-world data integration, and digital health systems.
Connect with leaders across cancer centers, biotech, technology, and government.
Learn how integrated data ecosystems are improving clinical decision making and patient outcomes.
Cizzle Bio’s Focus
As a company advancing biomarker blood tests for early cancer detection, Cizzle Bio recognizes the importance of informatics and data integration in accelerating progress across oncology.
Attending the Ci4CC Summit and Bill Behnke’s participation in this important panel discussion reflect our commitment to engaging with leaders who are shaping the future of precision medicine, translational research, and diagnostic innovation.